CN Stock MarketDetailed Quotes

002219 New Journey Health Technology Group

Watchlist
  • 2.24
  • +0.05+2.28%
Not Open Aug 6 15:00 CST
7.63BMarket Cap224.00P/E (TTM)

New Journey Health Technology Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Assets
Current assets
Money funds
-36.69%493.71M
3.73%580.24M
-8.65%590M
-42.70%656.68M
-60.97%779.89M
-72.49%559.38M
203.33%645.84M
649.06%1.15B
1,467.55%2B
1,084.46%2.03B
Transactional financial assets
----
----
--100K
----
----
----
----
----
----
----
Notes receivable and accounts receivable
29.98%1.09B
33.82%1.03B
45.86%998.97M
43.41%981.14M
33.94%838.94M
35.56%771.31M
5.90%684.86M
4.14%684.16M
5.12%626.34M
-1.66%568.98M
-Notes receivable
-68.47%4.56M
-44.91%9.12M
-46.59%6.57M
-17.08%10.06M
47.42%14.46M
46.31%16.55M
-3.09%12.31M
-30.21%12.13M
-25.09%9.81M
15.33%11.31M
-Accounts receivable
31.70%1.09B
35.55%1.02B
47.56%992.39M
44.50%971.08M
33.73%824.48M
35.34%754.76M
6.08%672.55M
5.08%672.03M
5.80%616.53M
-1.95%557.67M
Other receivables (including interest and dividends)
55.15%166.4M
-35.86%88.69M
1.97%173M
7.27%159.24M
-21.30%107.25M
-2.12%138.28M
-13.47%169.66M
-22.86%148.45M
-36.79%136.28M
-30.82%141.28M
-Other receivable
----
----
----
7.27%159.24M
----
-2.12%138.28M
----
-22.86%148.45M
----
-30.82%141.28M
Advance payment
-52.89%25.41M
-44.82%19.3M
-50.25%32.71M
-54.98%31.93M
-14.29%53.94M
-52.72%34.97M
-19.35%65.76M
34.85%70.93M
-32.04%62.92M
32.30%73.97M
Inventories
35.75%229.99M
31.43%218.55M
27.19%228.79M
-6.97%161.12M
-9.23%169.43M
-10.25%166.29M
2.73%179.88M
6.08%173.19M
6.44%186.65M
3.93%185.27M
Assets held for sale
----
----
--45.1M
--29.15M
----
--111.73M
----
----
----
----
Other current assets
54.52%21.1M
-4.78%17.05M
-29.18%15.52M
-89.71%12.27M
-30.28%13.65M
-15.44%17.91M
147.94%21.92M
1,276.49%119.16M
122.25%19.58M
105.07%21.18M
Total current assets
3.26%2.03B
8.67%1.96B
17.89%2.08B
-13.25%2.03B
-35.21%1.96B
-40.48%1.8B
33.81%1.77B
90.88%2.34B
149.24%3.03B
152.21%3.02B
Non Current assets
Long-term equity investment
16.49%6.87M
16.49%6.87M
14.58%7M
-1.79%6M
-3.43%5.9M
-3.43%5.9M
-50.13%6.11M
-50.13%6.11M
-50.13%6.11M
-50.13%6.11M
Fixed assets
----
----
----
19.41%1.85B
----
19.10%1.84B
----
-1.87%1.55B
----
-3.78%1.55B
Fixed assets liquidation
----
----
----
--456.85K
----
--785.57K
----
----
----
----
Constru in process
----
----
----
-25.02%547.29M
----
-20.66%528.62M
----
11.63%729.88M
----
15.36%666.26M
Productive biological assets
--925K
--950K
----
----
----
----
----
----
----
----
Intangible assets
14.70%301.31M
14.61%304.41M
5.14%300.92M
-1.24%262.88M
-1.94%262.7M
-2.11%265.6M
6.04%286.21M
-1.93%266.19M
1.24%267.9M
1.42%271.34M
Development expenditure
----
----
----
----
----
----
-12.86%2.68M
-12.86%2.68M
-12.86%2.68M
-12.86%2.68M
Goodwill
7.34%949.01M
7.34%949.01M
7.37%949.25M
0.00%884.1M
0.00%884.1M
0.00%884.1M
-10.40%884.1M
-10.40%884.1M
-10.40%884.1M
-10.40%884.1M
Long deferred expense
5.42%66.51M
-1.93%64.93M
-1.70%66.08M
-5.67%61.84M
-8.82%63.09M
-0.44%66.21M
17.71%67.22M
26.09%65.56M
36.45%69.19M
29.21%66.5M
Deferred tax assets
12.71%164.91M
5.35%160.38M
29.76%164.33M
22.04%153.98M
15.97%146.32M
20.65%152.23M
19.22%126.64M
18.78%126.17M
18.78%126.17M
18.78%126.17M
Usufruct assets
15.67%104.64M
9.05%108.59M
-23.18%83.93M
-22.46%84.79M
-23.36%90.46M
4.25%99.58M
--109.25M
--109.36M
336.60%118.03M
7,062.70%95.53M
Other non current assets
12.83%24.57M
96.94%23.18M
2,066.22%26.55M
2,811.80%23.36M
2,367.12%21.78M
1,624.65%11.77M
-50.94%1.23M
-80.94%802.41K
-89.52%882.61K
-91.49%682.53K
Total non current assets
7.53%4.16B
6.92%4.12B
9.12%4.08B
3.59%3.87B
3.30%3.87B
5.21%3.86B
1.93%3.73B
1.96%3.74B
3.79%3.75B
1.23%3.67B
Total assets
6.09%6.19B
7.48%6.08B
11.94%6.16B
-2.90%5.9B
-13.92%5.83B
-15.44%5.66B
10.38%5.5B
24.25%6.08B
40.44%6.78B
38.78%6.69B
Liabilities
Current liabilities
Short term loan
12.58%768.97M
127.98%716.49M
626.32%725.23M
382.59%699.04M
-45.19%683.06M
-75.34%314.27M
-92.32%99.85M
-88.97%144.85M
-5.56%1.25B
-3.81%1.27B
Notes payable and accounts payable
23.37%1.42B
14.59%1.33B
24.37%1.28B
21.84%1.23B
11.82%1.15B
16.25%1.16B
11.23%1.03B
15.24%1.01B
12.83%1.03B
14.36%1B
-Notes payable
18.14%48.19M
55.62%33.02M
-7.20%26.62M
71.76%54.46M
63.87%40.79M
-14.22%21.22M
19.69%28.69M
303.43%31.71M
128.77%24.89M
8.31%24.74M
-Accounts payable
23.56%1.38B
13.83%1.3B
25.28%1.25B
20.22%1.18B
10.53%1.11B
17.02%1.14B
11.00%1B
12.63%977.59M
11.44%1.01B
14.52%975.67M
Contract liabilities
59.68%3.93M
-1.22%3.06M
-27.83%4.25M
-51.93%2.45M
-57.75%2.46M
-45.20%3.09M
47.91%5.89M
46.69%5.09M
119.00%5.82M
52.09%5.65M
Advance receipts
16.40%56.1M
22.58%78.01M
38.68%73.37M
1.26%65.51M
-9.77%48.19M
7.00%63.64M
-3.80%52.91M
16.52%64.7M
7.25%53.41M
15.11%59.48M
Salaries payable
-11.99%104.05M
-11.03%113.68M
31.93%101.24M
57.97%121.2M
13.23%118.22M
-4.41%127.77M
-10.36%76.74M
-20.56%76.72M
24.31%104.41M
36.47%133.67M
Taxs payable
-54.29%22.91M
-43.62%33.89M
-43.16%37.72M
-25.72%44.93M
-3.58%50.13M
12.88%60.11M
95.85%66.36M
90.62%60.5M
39.10%51.99M
0.25%53.25M
Other payable (including interest and dividends)
-27.62%407.14M
-37.87%435.78M
-13.50%611.69M
-55.83%560.3M
-55.91%562.52M
-41.66%701.38M
-62.12%707.16M
28.96%1.27B
38.82%1.28B
38.07%1.2B
-Interest payable
-25.62%4.61M
-11.07%7.2M
-70.60%3.52M
-99.81%371.87K
-96.53%6.2M
-94.90%8.09M
158.61%11.98M
1,456.59%198.58M
1,269.76%178.64M
823.82%158.83M
-Dividend payable
0.00%6.18K
0.00%6.18K
0.00%6.18K
0.00%6.18K
0.00%6.18K
0.00%6.18K
0.00%6.18K
0.00%6.18K
0.00%6.18K
0.00%6.18K
-Other payable
-27.64%402.52M
-38.18%428.57M
-12.52%608.17M
-47.66%559.93M
-49.30%556.31M
-33.56%693.28M
-62.67%695.17M
10.20%1.07B
21.10%1.1B
22.25%1.04B
Hold and for sell liabilities
----
----
--27.54M
--2.6M
----
--80.36M
----
----
----
----
Non current liabilities due within one year
-70.38%219.36M
-74.24%209.54M
-78.52%213.37M
-81.66%170.94M
-10.78%740.63M
-1.90%813.51M
5,424.46%993.32M
14.25%932.25M
4.79%830.07M
2.19%829.26M
Other current liabilities
223.85%367.86K
127.55%252.76K
--3.86M
--139K
--113.59K
--111.08K
----
----
----
----
Total current liabilities
-10.50%3.01B
-12.14%2.92B
1.55%3.08B
-18.67%2.9B
-26.96%3.36B
-27.01%3.33B
-29.32%3.03B
-14.70%3.56B
11.67%4.6B
11.50%4.56B
Current liabilities
Long term loan
148.55%697.31M
75.95%722.24M
30.25%758.1M
10.41%701.79M
2.88%280.55M
46.63%410.49M
101.87%582.05M
119.97%635.63M
-5.62%272.71M
-3.46%279.96M
Long term account payable
----
----
----
-41.87%59.12M
----
-34.25%46.35M
----
56.67%101.7M
----
3.63%70.5M
Specific account payable
----
----
----
83.78%2.46M
----
7.37%1.44M
----
9.13%1.34M
----
-2.42%1.34M
Estimate liabilities
3.66%1.58M
13.10%1.78M
-97.39%576.03K
-93.50%1.6M
--1.52M
-98.20%1.57M
-88.94%22.05M
-87.56%24.55M
----
-43.20%87.13M
Deferred tax liabilities
-34.25%29.24M
-46.71%29.56M
7.08%53.96M
-9.44%45.82M
2,227.26%44.48M
12.32%55.48M
0.23%50.39M
-0.70%50.6M
-96.31%1.91M
-5.97%49.39M
Long term deferred income
-8.19%2.26M
36.64%2.88M
-9.30%2.11M
11.99%2.09M
-97.14%2.46M
-0.33%2.11M
11.98%2.33M
-51.40%1.86M
1,212.99%86.11M
-75.61%2.11M
Lease liabilities
60.06%65.87M
58.93%74.7M
-6.22%54.17M
-6.98%55.94M
-52.03%41.15M
-15.07%47M
--57.76M
--60.14M
387.62%85.8M
7,716.19%55.34M
Other non current liabilities
----
----
----
----
----
----
----
----
--49.39M
----
Total non current liabilities
110.79%895.16M
63.42%922.41M
21.27%925.97M
-0.80%868.82M
-27.73%424.67M
3.42%564.44M
28.16%763.59M
44.23%875.8M
-1.48%587.58M
-5.03%545.77M
Total liabilities
3.11%3.9B
-1.18%3.85B
5.51%4B
-15.14%3.77B
-27.05%3.78B
-23.76%3.89B
-22.31%3.79B
-7.22%4.44B
10.00%5.19B
9.46%5.1B
Shareholders equity
Paid-in capital
0.86%3.41B
4.49%3.41B
3.60%3.38B
3.60%3.38B
81.30%3.38B
75.00%3.26B
75.00%3.26B
75.00%3.26B
0.00%1.87B
0.00%1.87B
Capital reserve funds
11.34%1.74B
20.75%1.72B
18.35%1.67B
14.99%1.62B
-44.18%1.57B
-49.34%1.42B
38.53%1.41B
38.53%1.41B
176.12%2.81B
176.12%2.81B
Surplus reserve funds
0.00%129.45M
0.00%129.45M
0.00%129.45M
0.00%129.45M
0.00%129.45M
0.00%129.45M
0.00%129.45M
0.00%129.45M
0.00%129.45M
0.00%129.45M
Retained profit
1.11%-3.04B
1.00%-3.06B
2.44%-3.06B
5.07%-3.04B
5.42%-3.07B
4.81%-3.09B
-6.82%-3.14B
-9.29%-3.2B
-11.04%-3.25B
-12.91%-3.25B
Shareholders equity without minority interests
12.00%2.25B
27.42%2.2B
27.17%2.12B
30.62%2.09B
29.10%2.01B
10.95%1.72B
2,127.15%1.67B
1,792.29%1.6B
1,694.55%1.55B
1,060.34%1.55B
Minority interests
-7.94%38.54M
-8.34%38.82M
-11.40%37.76M
12.11%44.85M
22.41%41.86M
28.42%42.35M
64.64%42.63M
50.29%40.01M
52.20%34.2M
37.45%32.98M
Total shareholder equity
11.59%2.29B
26.56%2.23B
26.21%2.16B
30.17%2.14B
28.95%2.05B
11.32%1.77B
1,596.68%1.71B
1,375.86%1.64B
1,356.26%1.59B
904.86%1.59B
Total liabilityies and equity
6.09%6.19B
7.48%6.08B
11.94%6.16B
-2.90%5.9B
-13.92%5.83B
-15.44%5.66B
10.38%5.5B
24.25%6.08B
40.44%6.78B
38.78%6.69B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion with explanatory notes
Auditor
--
Asia Pacific (Group) Accounting Firm (Special General Partnership)
--
--
--
Asia Pacific (Group) Accounting Firm (Special General Partnership)
--
--
--
Asia Pacific (Group) Accounting Firm (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Assets
Current assets
Money funds -36.69%493.71M3.73%580.24M-8.65%590M-42.70%656.68M-60.97%779.89M-72.49%559.38M203.33%645.84M649.06%1.15B1,467.55%2B1,084.46%2.03B
Transactional financial assets ----------100K----------------------------
Notes receivable and accounts receivable 29.98%1.09B33.82%1.03B45.86%998.97M43.41%981.14M33.94%838.94M35.56%771.31M5.90%684.86M4.14%684.16M5.12%626.34M-1.66%568.98M
-Notes receivable -68.47%4.56M-44.91%9.12M-46.59%6.57M-17.08%10.06M47.42%14.46M46.31%16.55M-3.09%12.31M-30.21%12.13M-25.09%9.81M15.33%11.31M
-Accounts receivable 31.70%1.09B35.55%1.02B47.56%992.39M44.50%971.08M33.73%824.48M35.34%754.76M6.08%672.55M5.08%672.03M5.80%616.53M-1.95%557.67M
Other receivables (including interest and dividends) 55.15%166.4M-35.86%88.69M1.97%173M7.27%159.24M-21.30%107.25M-2.12%138.28M-13.47%169.66M-22.86%148.45M-36.79%136.28M-30.82%141.28M
-Other receivable ------------7.27%159.24M-----2.12%138.28M-----22.86%148.45M-----30.82%141.28M
Advance payment -52.89%25.41M-44.82%19.3M-50.25%32.71M-54.98%31.93M-14.29%53.94M-52.72%34.97M-19.35%65.76M34.85%70.93M-32.04%62.92M32.30%73.97M
Inventories 35.75%229.99M31.43%218.55M27.19%228.79M-6.97%161.12M-9.23%169.43M-10.25%166.29M2.73%179.88M6.08%173.19M6.44%186.65M3.93%185.27M
Assets held for sale ----------45.1M--29.15M------111.73M----------------
Other current assets 54.52%21.1M-4.78%17.05M-29.18%15.52M-89.71%12.27M-30.28%13.65M-15.44%17.91M147.94%21.92M1,276.49%119.16M122.25%19.58M105.07%21.18M
Total current assets 3.26%2.03B8.67%1.96B17.89%2.08B-13.25%2.03B-35.21%1.96B-40.48%1.8B33.81%1.77B90.88%2.34B149.24%3.03B152.21%3.02B
Non Current assets
Long-term equity investment 16.49%6.87M16.49%6.87M14.58%7M-1.79%6M-3.43%5.9M-3.43%5.9M-50.13%6.11M-50.13%6.11M-50.13%6.11M-50.13%6.11M
Fixed assets ------------19.41%1.85B----19.10%1.84B-----1.87%1.55B-----3.78%1.55B
Fixed assets liquidation --------------456.85K------785.57K----------------
Constru in process -------------25.02%547.29M-----20.66%528.62M----11.63%729.88M----15.36%666.26M
Productive biological assets --925K--950K--------------------------------
Intangible assets 14.70%301.31M14.61%304.41M5.14%300.92M-1.24%262.88M-1.94%262.7M-2.11%265.6M6.04%286.21M-1.93%266.19M1.24%267.9M1.42%271.34M
Development expenditure -------------------------12.86%2.68M-12.86%2.68M-12.86%2.68M-12.86%2.68M
Goodwill 7.34%949.01M7.34%949.01M7.37%949.25M0.00%884.1M0.00%884.1M0.00%884.1M-10.40%884.1M-10.40%884.1M-10.40%884.1M-10.40%884.1M
Long deferred expense 5.42%66.51M-1.93%64.93M-1.70%66.08M-5.67%61.84M-8.82%63.09M-0.44%66.21M17.71%67.22M26.09%65.56M36.45%69.19M29.21%66.5M
Deferred tax assets 12.71%164.91M5.35%160.38M29.76%164.33M22.04%153.98M15.97%146.32M20.65%152.23M19.22%126.64M18.78%126.17M18.78%126.17M18.78%126.17M
Usufruct assets 15.67%104.64M9.05%108.59M-23.18%83.93M-22.46%84.79M-23.36%90.46M4.25%99.58M--109.25M--109.36M336.60%118.03M7,062.70%95.53M
Other non current assets 12.83%24.57M96.94%23.18M2,066.22%26.55M2,811.80%23.36M2,367.12%21.78M1,624.65%11.77M-50.94%1.23M-80.94%802.41K-89.52%882.61K-91.49%682.53K
Total non current assets 7.53%4.16B6.92%4.12B9.12%4.08B3.59%3.87B3.30%3.87B5.21%3.86B1.93%3.73B1.96%3.74B3.79%3.75B1.23%3.67B
Total assets 6.09%6.19B7.48%6.08B11.94%6.16B-2.90%5.9B-13.92%5.83B-15.44%5.66B10.38%5.5B24.25%6.08B40.44%6.78B38.78%6.69B
Liabilities
Current liabilities
Short term loan 12.58%768.97M127.98%716.49M626.32%725.23M382.59%699.04M-45.19%683.06M-75.34%314.27M-92.32%99.85M-88.97%144.85M-5.56%1.25B-3.81%1.27B
Notes payable and accounts payable 23.37%1.42B14.59%1.33B24.37%1.28B21.84%1.23B11.82%1.15B16.25%1.16B11.23%1.03B15.24%1.01B12.83%1.03B14.36%1B
-Notes payable 18.14%48.19M55.62%33.02M-7.20%26.62M71.76%54.46M63.87%40.79M-14.22%21.22M19.69%28.69M303.43%31.71M128.77%24.89M8.31%24.74M
-Accounts payable 23.56%1.38B13.83%1.3B25.28%1.25B20.22%1.18B10.53%1.11B17.02%1.14B11.00%1B12.63%977.59M11.44%1.01B14.52%975.67M
Contract liabilities 59.68%3.93M-1.22%3.06M-27.83%4.25M-51.93%2.45M-57.75%2.46M-45.20%3.09M47.91%5.89M46.69%5.09M119.00%5.82M52.09%5.65M
Advance receipts 16.40%56.1M22.58%78.01M38.68%73.37M1.26%65.51M-9.77%48.19M7.00%63.64M-3.80%52.91M16.52%64.7M7.25%53.41M15.11%59.48M
Salaries payable -11.99%104.05M-11.03%113.68M31.93%101.24M57.97%121.2M13.23%118.22M-4.41%127.77M-10.36%76.74M-20.56%76.72M24.31%104.41M36.47%133.67M
Taxs payable -54.29%22.91M-43.62%33.89M-43.16%37.72M-25.72%44.93M-3.58%50.13M12.88%60.11M95.85%66.36M90.62%60.5M39.10%51.99M0.25%53.25M
Other payable (including interest and dividends) -27.62%407.14M-37.87%435.78M-13.50%611.69M-55.83%560.3M-55.91%562.52M-41.66%701.38M-62.12%707.16M28.96%1.27B38.82%1.28B38.07%1.2B
-Interest payable -25.62%4.61M-11.07%7.2M-70.60%3.52M-99.81%371.87K-96.53%6.2M-94.90%8.09M158.61%11.98M1,456.59%198.58M1,269.76%178.64M823.82%158.83M
-Dividend payable 0.00%6.18K0.00%6.18K0.00%6.18K0.00%6.18K0.00%6.18K0.00%6.18K0.00%6.18K0.00%6.18K0.00%6.18K0.00%6.18K
-Other payable -27.64%402.52M-38.18%428.57M-12.52%608.17M-47.66%559.93M-49.30%556.31M-33.56%693.28M-62.67%695.17M10.20%1.07B21.10%1.1B22.25%1.04B
Hold and for sell liabilities ----------27.54M--2.6M------80.36M----------------
Non current liabilities due within one year -70.38%219.36M-74.24%209.54M-78.52%213.37M-81.66%170.94M-10.78%740.63M-1.90%813.51M5,424.46%993.32M14.25%932.25M4.79%830.07M2.19%829.26M
Other current liabilities 223.85%367.86K127.55%252.76K--3.86M--139K--113.59K--111.08K----------------
Total current liabilities -10.50%3.01B-12.14%2.92B1.55%3.08B-18.67%2.9B-26.96%3.36B-27.01%3.33B-29.32%3.03B-14.70%3.56B11.67%4.6B11.50%4.56B
Current liabilities
Long term loan 148.55%697.31M75.95%722.24M30.25%758.1M10.41%701.79M2.88%280.55M46.63%410.49M101.87%582.05M119.97%635.63M-5.62%272.71M-3.46%279.96M
Long term account payable -------------41.87%59.12M-----34.25%46.35M----56.67%101.7M----3.63%70.5M
Specific account payable ------------83.78%2.46M----7.37%1.44M----9.13%1.34M-----2.42%1.34M
Estimate liabilities 3.66%1.58M13.10%1.78M-97.39%576.03K-93.50%1.6M--1.52M-98.20%1.57M-88.94%22.05M-87.56%24.55M-----43.20%87.13M
Deferred tax liabilities -34.25%29.24M-46.71%29.56M7.08%53.96M-9.44%45.82M2,227.26%44.48M12.32%55.48M0.23%50.39M-0.70%50.6M-96.31%1.91M-5.97%49.39M
Long term deferred income -8.19%2.26M36.64%2.88M-9.30%2.11M11.99%2.09M-97.14%2.46M-0.33%2.11M11.98%2.33M-51.40%1.86M1,212.99%86.11M-75.61%2.11M
Lease liabilities 60.06%65.87M58.93%74.7M-6.22%54.17M-6.98%55.94M-52.03%41.15M-15.07%47M--57.76M--60.14M387.62%85.8M7,716.19%55.34M
Other non current liabilities ----------------------------------49.39M----
Total non current liabilities 110.79%895.16M63.42%922.41M21.27%925.97M-0.80%868.82M-27.73%424.67M3.42%564.44M28.16%763.59M44.23%875.8M-1.48%587.58M-5.03%545.77M
Total liabilities 3.11%3.9B-1.18%3.85B5.51%4B-15.14%3.77B-27.05%3.78B-23.76%3.89B-22.31%3.79B-7.22%4.44B10.00%5.19B9.46%5.1B
Shareholders equity
Paid-in capital 0.86%3.41B4.49%3.41B3.60%3.38B3.60%3.38B81.30%3.38B75.00%3.26B75.00%3.26B75.00%3.26B0.00%1.87B0.00%1.87B
Capital reserve funds 11.34%1.74B20.75%1.72B18.35%1.67B14.99%1.62B-44.18%1.57B-49.34%1.42B38.53%1.41B38.53%1.41B176.12%2.81B176.12%2.81B
Surplus reserve funds 0.00%129.45M0.00%129.45M0.00%129.45M0.00%129.45M0.00%129.45M0.00%129.45M0.00%129.45M0.00%129.45M0.00%129.45M0.00%129.45M
Retained profit 1.11%-3.04B1.00%-3.06B2.44%-3.06B5.07%-3.04B5.42%-3.07B4.81%-3.09B-6.82%-3.14B-9.29%-3.2B-11.04%-3.25B-12.91%-3.25B
Shareholders equity without minority interests 12.00%2.25B27.42%2.2B27.17%2.12B30.62%2.09B29.10%2.01B10.95%1.72B2,127.15%1.67B1,792.29%1.6B1,694.55%1.55B1,060.34%1.55B
Minority interests -7.94%38.54M-8.34%38.82M-11.40%37.76M12.11%44.85M22.41%41.86M28.42%42.35M64.64%42.63M50.29%40.01M52.20%34.2M37.45%32.98M
Total shareholder equity 11.59%2.29B26.56%2.23B26.21%2.16B30.17%2.14B28.95%2.05B11.32%1.77B1,596.68%1.71B1,375.86%1.64B1,356.26%1.59B904.86%1.59B
Total liabilityies and equity 6.09%6.19B7.48%6.08B11.94%6.16B-2.90%5.9B-13.92%5.83B-15.44%5.66B10.38%5.5B24.25%6.08B40.44%6.78B38.78%6.69B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion with explanatory notes
Auditor --Asia Pacific (Group) Accounting Firm (Special General Partnership)------Asia Pacific (Group) Accounting Firm (Special General Partnership)------Asia Pacific (Group) Accounting Firm (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg